NCT00434122 - Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Infertility, Female

Interventions

DRUG

Degarelix mid-luteal, 2.5 mg

Degarelix 2.5 mg will be injected subcutaneously (SC) 7 days after luteinizing hormone (LH) peak and on Stimulation Day 6. Placebo will be injected SC on Stimulation Day 1.

DRUG

Placebo

"Placebo will be injected subcutaneously (SC) 7 days after luteinizing hormone (LH) peak. Degarelix 2.5 mg will be injected SC on Stimulation Day 1 and Stimulation Day 6.~or Placebo will be injected SC 7 days after LH peak and on Stimulation Day 1. Ganirelix 0.25 mg will be injected SC daily from Stimulation Day 6 until the last stimulation day."

Trial Locations (4)

Unknown

UZ Brussel, Brussels

ISCARE IVF a.s., Prague

IVI-Madrid, Madrid

IVI-Valencia, Valencia